Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Administration, Oral (1)
- Adult (1)
- Anti-Inflammatory Agents, Non-Steroidal (1)
- Antigens, CD--blood (1)
- Blood Glucose (1)
-
- Blood Glucose--metabolism (1)
- Brachial Artery (1)
- Diabetes Mellitus, Type 2 (1)
- Dose-Response Relationship, Drug (1)
- Double-Blind Method (1)
- Drug Therapy, Combination (1)
- Endothelium, Vascular (1)
- Endothelium, Vascular--physiopathology (1)
- Female (1)
- Follow-Up Studies (1)
- Humans (1)
- Hypoglycemic Agents (1)
- Inflammation (1)
- Inflammation--drug therapy (1)
- Male (1)
- Middle Aged (1)
- Pre-Eclampsia--blood (1)
- Pregnancy Proteins--blood (1)
- Pregnancy Trimester, First--blood (1)
- Pregnancy Trimester, Second--blood (1)
- Receptors, Cell Surface--blood (1)
- Regional Blood Flow (1)
- Salicylates (1)
- Salicylates--administration & dosage (1)
- Single-Blind Method (1)
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Targeting Inflammation Using Salsalate In Patients With Type 2 Diabetes: Effects On Flow-Mediated Dilation (Tinsal-Fmd)., Allison B Goldfine, J Stewart Buck, Cyrus Desouza, Vivian Fonseca, Yii-Der Ida Chen, Steven E Shoelson, Kathleen A. Jablonski, Mark A Creager, The Tinsal-Fmd Team
Targeting Inflammation Using Salsalate In Patients With Type 2 Diabetes: Effects On Flow-Mediated Dilation (Tinsal-Fmd)., Allison B Goldfine, J Stewart Buck, Cyrus Desouza, Vivian Fonseca, Yii-Der Ida Chen, Steven E Shoelson, Kathleen A. Jablonski, Mark A Creager, The Tinsal-Fmd Team
GW Biostatistics Center
OBJECTIVE: To test whether inhibiting inflammation with salsalate improves endothelial function in patients with type 2 diabetes (T2D).
RESEARCH DESIGN AND METHODS: We conducted an ancillary study to the National Institutes of Health-sponsored, multicenter, randomized, double-masked, placebo-controlled trial evaluating the safety and efficacy of salsalate in targeting inflammation to improve glycemia in patients with T2D. Flow-mediated, endothelium-dependent dilation (FMD) and endothelium-independent, nitroglycerin-mediated dilation (NMD) of the brachial artery were assessed at baseline and 3 and 6 months following randomization to either salsalate 3.5 g/day or placebo. The primary end point was change in FMD at 6 months.
RESULTS: A total …
Can Changes In Angiogenic Biomarkers Between The First And Second Trimesters Of Pregnancy Predict Development Of Pre-Eclampsia In A Low-Risk Nulliparous Patient Population?, Leslie Myatt, Rebecca G. Clifton, J. M. Roberts, Catherine Y. Spong, Ronald J. Wapner, +10 Additional Authors
Can Changes In Angiogenic Biomarkers Between The First And Second Trimesters Of Pregnancy Predict Development Of Pre-Eclampsia In A Low-Risk Nulliparous Patient Population?, Leslie Myatt, Rebecca G. Clifton, J. M. Roberts, Catherine Y. Spong, Ronald J. Wapner, +10 Additional Authors
GW Biostatistics Center
OBJECTIVE:
To determine if change in maternal angiogenic biomarkers between the first and second trimesters predicts pre-eclampsia in low-risk nulliparous women.
DESIGN:
A nested case-control study of change in maternal plasma soluble Flt-1 (sFlt-1), soluble endoglin (sEng) and placenta growth factor (PlGF). We studied 158 pregnancies complicated by pre-eclampsia and 468 normotensive nonproteinuric controls.
SETTING:
A multicentre study in 16 academic medical centres in the USA.
POPULATION:
Low-risk nulliparous women.
METHODS:
Luminex assays for PlGF, sFlt-1 and sEng performed on maternal EDTA plasma collected at 9-12, 15-18 and 23-26 weeks of gestation. Rate of change of analyte between first and …
Obesity And Preference-Weighted Quality Of Life Of Ethnically Diverse Middle School Children: The Healthy Study, Roberto P. Trevino, Trang H. Pham, Sharon Edelstein
Obesity And Preference-Weighted Quality Of Life Of Ethnically Diverse Middle School Children: The Healthy Study, Roberto P. Trevino, Trang H. Pham, Sharon Edelstein
GW Biostatistics Center
No abstract provided.